“…Therapeutics that decrease the activation of the mitochondrial fission proteins such as Drp1, pTau, and Aβ can rescue the neurons from the toxic effects of those agents and their interconnection. A diversity of phytochemicals available in numerous plant sources demonstrate various pharmacological properties, including neuroprotection [ 93 , 94 ], apoptosis induction [ 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 ], autophagy activation [ 79 , 103 , 104 , 105 ], antioxidant [ 106 ] and anti-inflammatory action [ 107 ], and DNA repair function [ 13 ]. Because of these capabilities, phytochemicals are progressively considered as favorable therapeutic candidates for AD therapy [ 10 ] ( Figure 4 ).…”